These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34185620)

  • 21. Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trial.
    Vachiéry JL; Galiè N; Barberá JA; Frost AE; Ghofrani HA; Hoeper MM; McLaughlin VV; Peacock AJ; Simonneau G; Blair C; Miller KL; Langley J; Rubin LJ;
    J Heart Lung Transplant; 2019 Feb; 38(2):194-202. PubMed ID: 30522722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
    Zijlstra WMH; Douwes JM; Rosenzweig EB; Schokker S; Krishnan U; Roofthooft MTR; Miller-Reed K; Hillege HL; Ivy DD; Berger RMF
    J Am Coll Cardiol; 2014 May; 63(20):2159-2169. PubMed ID: 24681143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
    Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
    Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres.
    Wissmüller M; Xanthouli P; Benjamin N; Grünig E; Richter MJ; Gall H; Ghofrani HA; Herkenrath S; Skowasch D; Pizarro C; Halank M; Hohmann C; Hellmich M; Gerhardt F; Rosenkranz S
    ESC Heart Fail; 2022 Oct; 9(5):2873-2885. PubMed ID: 35706353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases.
    Torbicki A; Bacchi M; Delcroix M; Farber HW; Ghofrani HA; Hennessy B; Jansa P; Mehta S; Perchenet L; Pulido T; Rosenberg D; Rubin LJ; Sastry BKS; Simonneau G; Sitbon O; Souza R; Wei LJ; Channick R; Benza R
    Circ Cardiovasc Qual Outcomes; 2019 May; 12(5):e005095. PubMed ID: 31109190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension.
    Tamura Y; Kumamaru H; Satoh T; Miyata H; Ogawa A; Tanabe N; Hatano M; Yao A; Abe K; Tsujino I; Fukuda K; Kimura H; Kuwana M; Matsubara H; Tatsumi K;
    Circ J; 2017 Dec; 82(1):275-282. PubMed ID: 28747612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension.
    White RJ; Vonk-Noordegraaf A; Rosenkranz S; Oudiz RJ; McLaughlin VV; Hoeper MM; Grünig E; Ghofrani HA; Chakinala MM; Barberà JA; Blair C; Langley J; Frost AE
    Respir Res; 2019 Sep; 20(1):208. PubMed ID: 31511080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension.
    Parikh KS; Doerfler S; Shelburne N; Kennedy K; Whitson J; Dahhan T; Fortin T; Rajagopal S
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):299-304. PubMed ID: 31934912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE.
    Kim NH; Hemnes AR; Chakinala MM; Highland KB; Chin KM; McLaughlin V; Zhao C; Narayan V; Farber HW
    J Heart Lung Transplant; 2021 Apr; 40(4):279-288. PubMed ID: 33526303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Long-Term Oral Bosentan in Different Types of Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Kuang HY; Li Q; Du HA; Chen M; Yin YH
    Am J Cardiovasc Drugs; 2021 Mar; 21(2):181-191. PubMed ID: 32918210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selexipag for the treatment of pulmonary arterial hypertension.
    Genecand L; Wacker J; Beghetti M; Lador F
    Expert Rev Respir Med; 2021 May; 15(5):583-595. PubMed ID: 33382345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study.
    Gaine S; Sitbon O; Channick RN; Chin KM; Sauter R; Galiè N; Hoeper MM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Tapson V; Ghofrani HA; Lang I
    Chest; 2021 Jul; 160(1):277-286. PubMed ID: 33545163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension.
    D'Alto M; Badagliacca R; Lo Giudice F; Argiento P; Casu G; Corda M; Correale M; Ghio S; Greco A; Lattanzio M; Mercurio V; Paciocco G; Papa S; Prediletto R; Romeo E; Russo MG; Tayar A; Vitulo P; Vizza CD; Golino P; Naeije R
    J Heart Lung Transplant; 2020 Dec; 39(12):1389-1397. PubMed ID: 32933828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
    Hoeper MM; McLaughlin VV; Barberá JA; Frost AE; Ghofrani HA; Peacock AJ; Simonneau G; Rosenkranz S; Oudiz RJ; White RJ; Miller KL; Langley J; Harris JHN; Blair C; Rubin LJ; Vachiery JL
    Lancet Respir Med; 2016 Nov; 4(11):894-901. PubMed ID: 27745818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 38. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.
    McLaughlin VV; Vachiery JL; Oudiz RJ; Rosenkranz S; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Peacock AJ; Simonneau G; Rubin LJ; Blair C; Langley J; Hoeper MM;
    J Heart Lung Transplant; 2019 Dec; 38(12):1286-1295. PubMed ID: 31648845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 40. Effectiveness and safety of endothelin receptor antagonists, alone and in combination therapy, in the pulmonary arterial hypertension-connective tissue disease subtype: A systematic review and meta-analysis.
    Shivakumar S; Thynne TR; Mohammadi L; Burdeniuk C; Mangoni AA
    Int J Rheum Dis; 2020 Oct; 23(10):1276-1287. PubMed ID: 32691518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.